We further analyzed the prognostic value of LGALS9 expression across cancer types and identified significant associations of high levels of LGALS9 with shorter overall survival for renal cell carcinoma and glioma patients (Fig. 8C, D). This evidence concerns the gene LGALS9 and central nervous system cancer.